Assignee
PROTAGEN AG
DE·5 granted patents·24 pending applications·0 citations·filing 2004–2017
Top patents by PatentIndex Score
29 records- 0157US2006188887A1Method and system for elucidating the primary structure of biopolymersPROTAGEN AG·Filed 2004·Application pending·0 cites
- 0256US9588115B2Method for the diagnosis of neuromyelitis opticaPROTAGEN AG·Filed 2014·Granted Mar 7, 2017·0 cites·3 claims
- 0353US10036746B2Method for the diagnosis of neuromyelitis opticaPROTAGEN AG·Filed 2017·Granted Jul 31, 2018·0 cites·6 claims
- 0451US10571477B2Marker sequences for diagnosing and stratifying systemic sclerosis patientsPROTAGEN AG·Filed 2015·Granted Feb 25, 2020·0 cites·11 claims
- 0551US2008118515A1Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of DiseasesPROTAGEN AG·Filed 2004·Application pending·0 cites
- 0650US2015087548A1Marker sequences for rheumatoid arthritis and use thereofPROTAGEN AG·Filed 2014·Application pending·0 cites
- 0750US2015024962A1Marker sequences for multiple sclerosis and use thereofPROTAGEN AG·Filed 2014·Application pending·0 cites
- 0847US2017009300A1Marker sequences for rheumatoid arthritis and use thereofPROTAGEN AG·Filed 2016·Application pending·0 cites
- 0946US2011275528A1Marker sequences for inflammatory prostate diseases, prostate carcinoma and their usePROTAGEN AG·Filed 2009·Application pending·0 cites
- 1045US2011184375A1Marker sequence for neurodegenerative diseases and the use thereofPROTAGEN AG·Filed 2008·Application pending·0 cites
- 1145US2010280224A1Marker sequences for multiple sclerosis and use thereofPROTAGEN AG·Filed 2008·Application pending·0 cites
- 1244US2013217591A1Marker Sequences for Inflammatory Prostate Diseases, Prostate Carconoma and Their UsePROTAGEN AG·Filed 2013·Application pending·0 cites
- 1343US10746735B2Marker sequences for diagnosing and stratifying SLE patientsPROTAGEN AG·Filed 2015·Granted Aug 18, 2020·0 cites·4 claims
- 1443US2015197820A1Marker sequences for inflammatory prostate diseases, prostate carcinoma and their usePROTAGEN AG·Filed 2015·Application pending·0 cites
- 1543US2010261881A1Marker sequences for rheumatoid arthritis and use thereofPROTAGEN AG·Filed 2008·Application pending·0 cites
- 1641US2010062059A1S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such CompositionsPROTAGEN AG·Filed 2007·Application pending·0 cites
- 1739US2015293120A1Marker sequences for rheumatoid arthritisPROTAGEN AG·Filed 2013·Application pending·0 cites
- 1838US2010331201A1Protein biochip for the differential screening of protein-protein interactionsPROTAGEN AG·Filed 2007·Application pending·0 cites
- 1937US2009124509A1Protein-biochip for validating binding agentsPROTAGEN AG·Filed 2005·Application pending·0 cites
- 2036US2015323529A1Marker sequences for neuromyelitis optica (nmo) and use thereofPROTAGEN AG·Filed 2013·Application pending·0 cites
- 2135US2019128884A1Marker sequences for managing the therapy of rheumatoid arthritis patientsPROTAGEN AG·Filed 2017·Application pending·0 cites
- 2235US2014371095A1Novel method for identifying specific marker sequences for prostate cancerPROTAGEN AG·Filed 2012·Application pending·0 cites
- 2333US2006115841A1Method and system for elucidating the primary structure of biopolymersPROTAGEN AG·Filed 2005·Application pending·0 cites
- 2432US2019120834A1Marker sequences for rheumatoid arthritisPROTAGEN AG·Filed 2017·Application pending·0 cites
- 2531US2014371098A1Marker sequences for breast cancer and the use thereofPROTAGEN AG·Filed 2012·Application pending·0 cites
- 2630US2014179557A1Marker sequences for diagnosing prostate cancer, and use thereofPROTAGEN AG·Filed 2014·Application pending·0 cites
- 2729US2013029864A1Biomarkers for alzheimer's diseasePROTAGEN AG·Filed 2010·Application pending·0 cites
- 2828US10677795B2Marker sequences for the diagnosis and stratification of systemic sclerosis patientsPROTAGEN AG·Filed 2015·Granted Jun 9, 2020·0 cites·9 claims
- 2926US2015177247A1Method for identifying marker sequences for gynaecological malignant tumoursPROTAGEN AG·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →